People with metastatic cancer who regularly report their symptoms via a home-based electronic monitoring system experienced ...
In the absence of accessible, integrated, multidimensional patient data, the organ transplant system will remain both highly ...
Atrial fibrillation outcomes in patients from Asia and non-Asia countries: insights from GARFIELD-AF
Background Differences in the clinical outcomes and level of risk among Asian versus non-Asian patients with atrial fibrillation (AF) have been sparsely investigated.Objective To provide a ...
MALVERN, Pa., Feb. 05, 2025 (GLOBE NEWSWIRE) -- via IBN - Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies fo ...
2d
MyChesCo on MSNYPrime Unveils Automated Data Change Form to Revolutionize Clinical Trial ManagementYPrime has announced the launch of its Automated Data Change Form (DCF), an innovative feature within the latest release of ...
About Veru Inc. Veru is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of cardiometabolic diseases, oncology, and ARDS. The Company’s drug ...
A 2024 survey of eCOA professionals at sponsor organizations revealed that 50% of respondents identified eCOA Data Change ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results